jama semaglutide and #tirzepatide have improved #obesity treatment but necessitate careful dosing and lifestyle adjustments to manage gastrointestinal side effects and ensure sustainable weight loss. https://t.co/KpesYQJeTA Is #semaglutide safe and effective
Description
Discover how it compares to injectable weight-loss medications and if it's right for you.
How are they doing it
Little is known about the association of discontinuation of sodium-glucose cotransporter-2 (SGLT2) inhibitors and glucagon-like peptide-1 receptor agonists (GLP-1 RA) with outcomes in patients with CKD
If patients can achieve these outcomes earlier, the future treatment pathway could change dramatically
Learn what science says and what to watch out for before starting treatment.
Pfizer announced early Thursday morning that it has selected its preferred once-daily modified release formulation of danuglipron, a move that it said was a significant milestone in the obesity drug's development.
